Home > News > Interview: Intel research trio discuss 45-nm high-k
November 22nd, 2007
Interview: Intel research trio discuss 45-nm high-k
Abstract:
Intel Corp. started 2007 with a bang with a breakthrough in transistor design, one of the biggest advancements in 40 years. In fact, 45nm high-k then became one of the buzzwords early on as Intel drew first blood in its highly intense battle for processor supremacy.
Now, the company is on its way on ending the year on a high note as it speeds past other chipmakers who are still months away from having production-ready 45nm chips. Intel in November introduced its Penryn 45nm processors using high-k dielectric gate insulator to control leakage current.
Three Intel researchers — Robert Chau, Intel Senior Fellow, technology and manufacturing group director, transistor research and nanotechnology; Kaizad Mistry, 45nm program manager, logic technology development, technology and manufacturing Group; and Tahir Ghani, Fellow TMG, Portland technology development director, transistor technology and integration — who were part of the team behind the 45nm high-k metal gate success, talk about the highs and lows of the project and what motivated them to press on and move on to more challenging endeavors.
Source:
eetimes.com
Related News Press |
Chip Technology
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||